EUVIMEDEUVIMED entdecken
Open Access

Exploring fibroblast activation protein as an early biomarker in chronic lung allograft dysfunction

Yudai Miyashita iD, Taisuke Kaiho iD, Hideki Nagata iD, Takashi Hiroshima iD, Yusuke Sugiura iD, Kaijie Zhang iD, Megan E Kelly iD, Yuanqing Yan iD, Takahide Toyoda iD, Alicia Steffens iD, Haiying Sun iD, Hiam Abdala-Valencia iD und 7 weitere

European Respiratory Journal · 2026

DOI: 10.1183/13993003.01738-2025 ↗

Kurz gefasst

Fachartikel in der Zeitschrift European Respiratory Journal, 2026. Verfasst von Yudai Miyashita und 18 weiteren Autor:innen. Beteiligte Einrichtung: Division of Thoracic Surgery, Department of Surgery, Northwestern University Feinberg School of Medicine, Chicago, IL, USA. Hauptthemen laut MEDLINE: Lung Transplantation, Serine Endopeptidases, Membrane Proteins, Gelatinases. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 47 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCI NIH HHS, NHLBI NIH HHS, Division of Intramural Research.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Question Chronic lung allograft dysfunction (CLAD) is the leading cause of late graft failure after lung transplantation. Fibroblast activation protein (FAP) is selectively upregulated in activated fibroblasts under fibrotic conditions. We asked whether FAP expression is increased in CLAD and whether it can serve as an early diagnostic marker. Materials and methods We performed single-cell RNA sequencing on two murine orthotopic lung transplant models (C57BL/6→C57BL/10 and BALB/c→C57BL/6) and human lung tissue from five controls and five patients with CLAD. We quantified FAP expression by immunohistochemistry in transbronchial biopsies from 240 lung transplant recipients (62 with CLAD and 178 without CLAD). Receiver-operating characteristic curves determined an optimal FAP-positive area threshold. Kaplan–Meier analysis and Cox proportional hazards models assessed the association between FAP positivity and CLAD. Results In both murine and human single-cell data, FAP expression was confined to pathogenic fibroblast subsets and was significantly elevated in CLAD. In the clinical cohort, a threshold of 10.8% FAP-positive area discriminated chronic dysfunction with an area under the curve of 0.78 (95% CI 0.72–0.85), sensitivity of 65% and specificity of 84%. FAP positivity predicted shorter CLAD-free survival (p

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Lung TransplantationSerine EndopeptidasesMembrane ProteinsGelatinasesGraft RejectionHumansAnimalsMaleBiomarkersMiceFemaleMiddle AgedMice, Inbred C57BLMice, Inbred BALB CAllograftsEndopeptidasesLungFibroblastsAdultROC CurveProportional Hazards ModelsKaplan-Meier EstimateSingle-Cell AnalysisChronic Disease

Substanzen

BiomarkersSerine EndopeptidasesMembrane ProteinsEndopeptidasesGelatinases

Autor:innen und Institutionen

  • Division of Thoracic Surgery, Department of Surgery, Northwestern University Feinberg School of Medicine, Chicago, IL, USA.
  • These authors contributed equally to this work.
  • Department of General Thoracic Surgery, Graduate School of Medicine, Osaka University, Osaka, Japan.
  • Department of Neurological Surgery, Northwestern University Feinberg School of Medicine, Chicago, IL, USA.
  • Division of Pulmonary and Critical Care Medicine, Department of Medicine, Simpson Querrey Lung Institute for Translational Sciences, Northwestern University Feinberg School of Medicine, Chicago, IL, USA.
  • Comprehensive Transplant Center, Northwestern University Feinberg School of Medicine, Chicago, IL, USA.

ORCID-Profile: Yudai Miyashita, Taisuke Kaiho, Hideki Nagata, Takashi Hiroshima, Yusuke Sugiura, Kaijie Zhang, Megan E Kelly, Yuanqing Yan, Takahide Toyoda, Alicia Steffens, Haiying Sun, Hiam Abdala-Valencia, Toru Kimura, Bowen Wang, Carl Atkinson, Ankit Bharat, Takashi Kanou, Yasushi Shintani, Chitaru Kurihara

Förderung

  • NCI NIH HHS
  • NHLBI NIH HHS
  • Division of Intramural Research

Zitieren

APA

Miyashita, Y., Kaiho, T., Nagata, H., Hiroshima, T., Sugiura, Y., Zhang, K., Kelly, M. E., Yan, Y., Toyoda, T., Steffens, A., Sun, H., Abdala-Valencia, H., Kimura, T., Wang, B., Atkinson, C., Bharat, A., Kanou, T., Shintani, Y., & Kurihara, C. (2026). Exploring fibroblast activation protein as an early biomarker in chronic lung allograft dysfunction. European Respiratory Journal. https://doi.org/10.1183/13993003.01738-2025

Vancouver

Miyashita Y, Kaiho T, Nagata H, Hiroshima T, Sugiura Y, Zhang K, et al. Exploring fibroblast activation protein as an early biomarker in chronic lung allograft dysfunction. European Respiratory Journal. 2026. doi:10.1183/13993003.01738-2025

BibTeX
@article{Miyashita2026,
  author = {Miyashita, Yudai and Kaiho, Taisuke and Nagata, Hideki and Hiroshima, Takashi and Sugiura, Yusuke and Zhang, Kaijie and Kelly, Megan E and Yan, Yuanqing and Toyoda, Takahide and Steffens, Alicia and Sun, Haiying and Abdala-Valencia, Hiam and Kimura, Toru and Wang, Bowen and Atkinson, Carl and Bharat, Ankit and Kanou, Takashi and Shintani, Yasushi and Kurihara, Chitaru},
  title = {Exploring fibroblast activation protein as an early biomarker in chronic lung allograft dysfunction},
  journal = {European Respiratory Journal},
  year = {2026},
  doi = {10.1183/13993003.01738-2025}
}
Kostenlos starten →